Harmonization of postmortem donations for pediatric brain tumors and molecular characterization of diffuse midline gliomas
MetadataShow full item record
AbstractChildren diagnosed with brain tumors have the lowest overall survival of all pediatric cancers. Recent molecular studies have resulted in the discovery of recurrent driver mutations in many pediatric brain tumors. However, despite these molecular advances, the clinical outcomes of high grade tumors, including H3K27M diffuse midline glioma (H3K27M DMG), remain poor. To address the paucity of tissue for biological studies, we have established a comprehensive protocol for the coordination and processing of donated specimens at postmortem. Since 2010, 60 postmortem pediatric brain tumor donations from 26 institutions were coordinated and collected. Patient derived xenograft models and cell cultures were successfully created (76% and 44% of attempts respectively), irrespective of postmortem processing time. Histological analysis of mid-sagittal whole brain sections revealed evidence of treatment response, immune cell infiltration and the migratory path of infiltrating H3K27M DMG cells into other midline structures and cerebral lobes. Sequencing of primary and disseminated tumors confirmed the presence of oncogenic driver mutations and their obligate partners. Our findings highlight the importance of postmortem tissue donations as an invaluable resource to accelerate research, potentially leading to improved outcomes for children with aggressive brain tumors. Copyright 2020, The Author(s).
SponsorsMatthew Larson Foundation for Pediatric Brain; Pediatric Brain Tumor Foundation, PBTF
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85087368501&doi=10.1038%2fs41598-020-67764-2&partnerID=40&md5=965558fea5302d180894e3e93d98726a; http://hdl.handle.net/10713/13295
- Transcriptomic and epigenetic profiling of 'diffuse midline gliomas, H3 K27M-mutant' discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial location.
- Authors: Castel D, Philippe C, Kergrohen T, Sill M, Merlevede J, Barret E, Puget S, Sainte-Rose C, Kramm CM, Jones C, Varlet P, Pfister SM, Grill J, Jones DTW, Debily MA
- Issue date: 2018 Nov 5
- [Clinicopathological characteristics and prognosis of diffuse midline gliomas with histone H3K27M mutation: an analysis of 30 cases].
- Authors: Li HN, Shan CG, Fan CZ, Cheng LN, Wu SG, Liu MT, Jiang GY, Li Z
- Issue date: 2019 Mar 8
- Significance of H3K27M Mutation in "Nonmidline" High-Grade Gliomas of Cerebral Hemispheres.
- Authors: La Rocca G, Sabatino G, Altieri R, Signorelli F, Ricciardi L, Gessi M, Della Pepa GM
- Issue date: 2019 Nov
- Diffuse midline glioma-H3K27M mutant. A novel entity with a defining and specific IHC marker.
- Authors: Agarwal P, Aiyer HM
- Issue date: 2021 Apr-Jun
- Identification of prognostic markers in diffuse midline gliomas H3K27M-mutant.
- Authors: Dufour C, Perbet R, Leblond P, Vasseur R, Stechly L, Pierache A, Reyns N, Touzet G, Le Rhun E, Vinchon M, Maurage CA, Escande F, Renaud F
- Issue date: 2020 Jan